Abstract Details
|
Karol Estrada, PhD
PRESENTER |
No disclosure on file |
| Ahmed Enayetallah, PhD, MBBCh (BlueRock Therapeutics) | Dr. Enayetallah has received personal compensation for serving as an employee of Alexion. Dr. Enayetallah has received stock or an ownership interest from Alexion. Dr. Enayetallah has received stock or an ownership interest from AstraZeneca. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file |